Literature DB >> 33522236

Bisphosphonates, Old Friends of Bones and New Trends in Clinics.

Jéssica S Barbosa1,2, Filipe A Almeida Paz1, Susana Santos Braga2.   

Abstract

Bisphosphonates, used for a long time in osteoporosis management, are currently the target of intensive research, from pre-formulation studies to more advanced stages of clinical practice. This review presents an overview of the contributions of this family of compounds to human health, starting with the chemistry and clinical uses of bisphosphonates. Following this, their pharmacology is described, highlighting administration-borne handicaps and undesirable effects. The last three sections of the review describe the research efforts that seek to curb delivery-related issues and expand bisphosphonate use. Innovative routes and strategies of administration, such as nano-encapsulation for oral intake or injectable cements for local or in-bone delivery are presented, as well as the latest results of case studies or preclinical studies proposing new therapeutic indications for the clinically approved bisphosphonates. Finally, a selection of anti-infectious bisphosphonate new drug candidates is shown, with focus on the molecules reported in the last two decades.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33522236     DOI: 10.1021/acs.jmedchem.0c01292

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

Review 1.  Bone metastasis of hepatocellular carcinoma: facts and hopes from clinical and translational perspectives.

Authors:  Zhao Huang; Jingyuan Wen; Yufei Wang; Shenqi Han; Zhen Li; Xuemei Hu; Dongling Zhu; Zhenxiong Wang; Junnan Liang; Huifang Liang; Xiao-Ping Chen; Bixiang Zhang
Journal:  Front Med       Date:  2022-07-19       Impact factor: 9.927

2.  pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages.

Authors:  Leonard Kaps; Anne Huppertsberg; Niklas Choteschovsky; Adrian Klefenz; Feyza Durak; Babara Schrörs; Mustafa Diken; Emma Eichler; Sebastian Rosigkeit; Sascha Schmitt; Christian Leps; Alicia Schulze; Friedrich Foerster; Ernesto Bockamp; Bruno G De Geest; Kaloian Koynov; Hans-Joachim Räder; Stefan Tenzer; Federico Marini; Detlef Schuppan; Lutz Nuhn
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-15       Impact factor: 12.779

Review 3.  A Review on the Molecular Mechanisms of Action of Natural Products in Preventing Bone Diseases.

Authors:  Innocent U Okagu; Timothy P C Ezeorba; Rita N Aguchem; Ikenna C Ohanenye; Emmanuel C Aham; Sunday N Okafor; Carlotta Bollati; Carmen Lammi
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

4.  Oral Administration of Clostridium butyricum GKB7 Ameliorates Signs of Osteoarthritis in Rats.

Authors:  Sunny Li-Yun Chang; Yen-You Lin; Shan-Chi Liu; You-Shan Tsai; Shih-Wei Lin; Yen-Lien Chen; Chin-Chu Chen; Chih-Yuan Ko; Hsien-Te Chen; Wei-Cheng Chen; Chih-Hsin Tang
Journal:  Cells       Date:  2022-07-11       Impact factor: 7.666

5.  One-Pot Synthesis of Phosphinylphosphonate Derivatives and Their Anti-Tumor Evaluations.

Authors:  Jade Dussart-Gautheret; Julia Deschamp; Thibaut Legigan; Maelle Monteil; Evelyne Migianu-Griffoni; Marc Lecouvey
Journal:  Molecules       Date:  2021-12-15       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.